BioMark Diagnostics Inc. (BMKDF)
USD 0.15
(0.0%)
USD 0.15
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | -229.95 Thousand CAD | 170.14% |
| 2023 | -232.7 Thousand CAD | -629.68% |
| 2022 | 43.93 Thousand CAD | 421.01% |
| 2021 | -13.68 Thousand CAD | -105.2% |
| 2020 | 263.28 Thousand CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -62.75 Thousand CAD | 0.38% |
| 2024 Q2 | -48.38 Thousand CAD | 22.89% |
| 2024 Q3 | -57.76 Thousand CAD | -19.37% |
| 2024 FY | -229.95 Thousand CAD | 1.18% |
| 2024 Q4 | -61.04 Thousand CAD | -5.68% |
| 2023 Q1 | 35.9 Thousand CAD | 48.87% |
| 2023 Q4 | -62.99 Thousand CAD | -270.77% |
| 2023 Q2 | -55.64 Thousand CAD | -255.01% |
| 2023 Q3 | 36.88 Thousand CAD | 166.29% |
| 2023 FY | -232.7 Thousand CAD | -629.68% |
| 2022 FY | 43.93 Thousand CAD | 421.01% |
| 2022 Q4 | 24.11 Thousand CAD | 21.68% |
| 2022 Q3 | 19.81 Thousand CAD | 866.36% |
| 2022 Q2 | -2586.00 CAD | 0.04% |
| 2022 Q1 | -2587.00 CAD | 61.62% |
| 2021 Q4 | -6741.00 CAD | 0.0% |
| 2021 FY | -13.68 Thousand CAD | -105.2% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 Q3 | - CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2020 Q4 | - CAD | -100.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 FY | 263.28 Thousand CAD | 0.0% |
| 2020 Q3 | 263.28 Thousand CAD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2019 FY | - CAD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 Q2 | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 100.0% |
| 2016 Q3 | - CAD | -100.0% |
| 2016 Q2 | 4410.00 CAD | 0.0% |
| 2016 Q1 | - CAD | 100.0% |
| 2016 Q4 | -4410.00 CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 Q3 | 9200.00 CAD | 0.0% |
| 2015 Q4 | -9200.00 CAD | -200.0% |
| 2015 FY | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | -19.145% |
| Arrayit Corporation | 2.57 Million USD | 108.93% |
| Atlantic International Corp. | -154.23 Thousand USD | -49.092% |
| Biocept, Inc. | -2.58 Million USD | 91.094% |
| Bioqual, Inc. | 7.42 Million USD | 103.095% |
| CardioGenics Holdings Inc | - USD | Infinity% |
| DermTech, Inc. | 276 Thousand USD | 183.315% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 100.003% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | 112.817% |
| iMD Companies, Inc. | -23.63 Thousand USD | -872.839% |
| IDenta Corp. | 662.97 Thousand USD | 134.685% |
| Interpace Biosciences, Inc. | 23.04 Million USD | 100.998% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | 396.438% |
| InVitro International | 635.98 Thousand USD | 136.157% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | 103.504% |
| Many Bright Ideas Technologies Inc. | - USD | Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | 121.045% |
| NovelStem International Corp. | 12 Thousand USD | 2016.25% |
| Optigenex Inc. | -102.96 Thousand USD | -123.326% |
| PharmChem, Inc. | 3.9 Million USD | 105.89% |
| Proteome Sciences plc | 2.09 Million USD | 110.968% |
| Response Genetics, Inc | 3.94 Million USD | 105.833% |
| Rennova Health, Inc. | 6.26 Million USD | 103.668% |
| RushNet, Inc. | 1.1 Million USD | 120.817% |
| ScreenPro Security Inc. | 856.57 Thousand USD | 126.845% |
| Stella Diagnostics Inc. | - USD | Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | 43.046% |
| Todos Medical Ltd. | 4.31 Million USD | 105.335% |